Author: Vanessa Ngan, Staff Writer, 2003. Reviewed and updated by Dr Amanda Oakley Dermatologist, Hamilton, New Zealand; and Vanessa Ngan, Staff Writer; June 2014.
Atypical mycobacterial infections are infections caused by a species of mycobacterium other than Mycobacterium tuberculosis, the causative bacteria of pulmonary TB and extrapulmonary TB including cutaneous TB; and Mycobacterium leprae, the cause of leprosy.
Atypical mycobacteria may cause many different types of infections, which are divided into the following four clinical syndromes:
Pulmonary disease
Lymphadenitis
Skin and soft tissue disease
Disseminated disease
Skin infection tends to result in crustednodules and plaques.Abscesses may develop in skin and bone infection.
There are many different species of mycobacterium. To date at least 30 species of mycobacteria that do not cause tuberculosis or leprosy have been identified. Some of those causing atypical mycobacterial infections include:
Mycobacterium avium-intracellulare
Mycobacterium kansasii
Mycobacterium marinum
Mycobacterium ulcerans
Mycobacterium chelonae
Mycobacterium fortuitum
Mycobacterium abscessus
Mycobacterium avium-intracellulare and Mycobacterium kansasii primarily cause lung disease similar to pulmonary TB, whilst Mycobacterium marinum, Mycobacterium ulcerans, Mycobacterium fortuitum and Mycobacterium chelonae cause skin infections.
What are the clinical features of an atypical mycobacterial infection?
The clinical features of atypical mycobacterial infection depend on the infecting mycobacteria.
Mycobacterium avium-intracellulare
Also known as MAC (Mycobacterium avium complex)
Most common non-tuberculous mycobacterial infection associated with AIDS
Symptoms include fever, swollen lymph nodes, diarrhoea, fatigue, weight loss and shortness of breath
May develop into pulmonary MAC
Skin lesions are uncommon and non-specific
Mycobacterium kansasii
May cause a chronic infection of the lungs similar to pulmonary TB
Second most common non-tuberculous mycobacterial infection associated with AIDS
Symptoms include fever, swollen lymph nodes and lung crackles and wheezing
Skin lesions may occur either alone or as part of a more widespread disease
Mycobacterium marinum
Also known as fish tank granuloma, swimming pool granuloma
Uncommon infection that occurs most often in people with recreational or occupational exposure to contaminated freshwater or saltwater
Usually, a single lump or pustule that breaks down to form a crusty sore or abscess
Other lumps may occur around the initial lesion, particularly along the lines of lymphatic drainage (sporotrichoid forms)
Most often affects elbows, knees, top of feet, knuckles or fingers
Multiple lesions and widespread disease may occur in immunocompromised patients
How is an atypical mycobacterial infection diagnosed?
Atypical mycobacteria are diagnosed on the culture of tissue. Specific conditions are required, such as cool temperature, so the laboratory must be informed of the clinician's suspicion of this diagnosis. The infections have specific pathological features on skin biopsy.
Other diagnostic tools used include radiographic imaging studies and more recently, polymerase chain reaction (PCR) testing on swabs of ulcers or tissue biopsies.
What is the treatment of atypical mycobacterial infection?
Treatment of atypical mycobacterial infections depends upon the infecting organism and the severity of the infection. In most cases a course of antibiotics is necessary. These include rifampicin, ethambutol, isoniazid, minocycline, ciprofloxacin, clarithromycin, azithromycin and cotrimoxazole. Usually, treatment consists of a combination of drugs.
Consider the following points when treating atypical mycobacterial infections with antibiotics:
Mycobacterium marinum species are often resistant to isoniazid, streptomycin, pyrazinamide, and para-aminosalicylic acid. Effective antimicrobials include tetracyclines, fluoroquinolones, macrolides (eg, clarithromycin), rifampicin and sulfonamides (cotrimoxazole). Treatment should be for at least 4–6 weeks, and sometimes up to two months.
Mycobacterium kansasii should be treated with at least 3 drugs for 12–18 months. One of the drugs must be rifampicin, which is still the cornerstone of treatment for these infections.
Mycobacterium chelonae and M fortuitum are best treated with clarithromycin or azithromycin in localised infections, particularly if used with surgical debridement. Disseminated infections require combination treatment, usually a macrolide and an aminoglycoside eg, combinations of amikacin, tobramycin, imipenem, clarithromycin.
Treatment of Mycobacterium ulcerans is most successful if treatment is started in lesions less than 6 months old with a diameter less than 10 cm. Rifampicin and streptomycin are the currently recommended antibiotics.
Surgery is used as an adjunct to antibiotic treatment in patients with severe infection. Most lesions eventually spontaneously heal after 6–9 months but may leave behind extensive scarring and disfigurement.
AIDS patients on HIVprotease inhibitor drugs cannot be treated with rifampicin because rifampicin significantly increases the breakdown of these drugs. Rifabutin is a suitable alternative.
Surgical removal of infected lymph nodes and aggressive debridement of infected skin lesions is sometimes necessary. In severe cases, skin grafts may be necessary to repair the surgical wound.
Some infections will heal spontaneously, often leaving significant scarring.
References
Ed Rook A, Wilkinson DS, Ebling FJB, Champion RH, Burton JL. Textbook of Dermatology. Fourth edition. Blackwell Scientific Publications.